Bicocca Open Archive

Logo unimib boa
BRESCIANI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.127
EU - Europa 3.350
AS - Asia 1.421
SA - Sud America 74
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 10.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.023
IT - Italia 913
DE - Germania 627
SG - Singapore 562
RU - Federazione Russa 438
CN - Cina 389
IE - Irlanda 306
SE - Svezia 300
HK - Hong Kong 198
UA - Ucraina 191
GB - Regno Unito 161
CA - Canada 102
AT - Austria 91
FI - Finlandia 88
ID - Indonesia 76
BR - Brasile 70
IN - India 63
VN - Vietnam 55
FR - Francia 49
BE - Belgio 41
DK - Danimarca 37
NL - Olanda 27
TR - Turchia 22
PL - Polonia 19
CH - Svizzera 15
BG - Bulgaria 11
JP - Giappone 11
KR - Corea 11
CZ - Repubblica Ceca 10
IR - Iran 10
RO - Romania 7
EG - Egitto 6
ES - Italia 6
EU - Europa 5
TW - Taiwan 5
ZA - Sudafrica 5
EE - Estonia 4
PK - Pakistan 4
LT - Lituania 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
AR - Argentina 2
HU - Ungheria 2
KG - Kirghizistan 2
MX - Messico 2
MY - Malesia 2
PH - Filippine 2
PT - Portogallo 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LI - Liechtenstein 1
MA - Marocco 1
TJ - Tagikistan 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 10.998
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.573
Woodbridge 509
Wilmington 500
Frankfurt am Main 446
Chandler 444
Fairfield 436
Singapore 420
Ashburn 298
Dublin 297
Milan 268
Houston 237
Seattle 217
Hong Kong 197
Jacksonville 189
Dearborn 172
Cambridge 137
New York 135
Santa Clara 121
Princeton 112
Vienna 86
Jakarta 75
Nanjing 72
Helsinki 52
Shanghai 51
Altamura 45
Lawrence 42
Brussels 40
Rome 39
Council Bluffs 33
Beijing 32
Lachine 32
London 32
Guangzhou 30
San Diego 27
Moscow 26
Boardman 25
Fremont 25
Elora 23
Los Angeles 22
Nuremberg 22
Pune 22
Nanchang 21
Andover 20
Dong Ket 20
Shenyang 18
Hebei 17
Toronto 17
Changsha 16
Romola 16
Bari 15
Detroit 15
Munich 15
Carate Brianza 14
Chicago 14
Monza 14
Turin 13
Kunming 12
Sacramento 12
Falls Church 11
Hangzhou 11
Jinan 10
Ningbo 10
Plovdiv 10
Huizen 9
Jiaxing 9
Kocaeli 9
Melzo 9
Mountain View 9
Ottawa 8
Padova 8
Russi 8
São Paulo 8
Tianjin 8
Tokyo 8
Brno 7
Busto Arsizio 7
Edmonton 7
Norwalk 7
Taizhou 7
Chiavari 6
Kiev 6
Pescara 6
Philadelphia 6
Thunder Bay 6
Arcore 5
Auburn Hills 5
Bergamo 5
Bodio Lomnago 5
Brescia 5
Bresso 5
Düsseldorf 5
Genoa 5
Hefei 5
Pavia 5
Tampa 5
Zhengzhou 5
Zurich 5
Bologna 4
Bolzano 4
Bonndorf 4
Totale 8.117
Salva come PNG Salva come JPEG
Nome #
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 372
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 361
Growth hormone secretagogues and the regulation of calcium signaling in muscle 338
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 330
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 328
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 304
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 289
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 262
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 249
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 240
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 234
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 226
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 223
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 217
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 215
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 211
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 204
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 201
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 199
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 197
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 197
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 196
Feeding behavior during long-term hexarelin administration in young and old rats 195
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 193
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 188
Ghrelin in gastroenteric pathophysiology 187
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 182
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 179
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 174
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 173
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 173
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 171
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 171
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 171
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 168
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 162
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 159
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 158
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 156
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 155
Androgen therapy in neurodegenerative diseases 154
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 149
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 149
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 149
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 145
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 142
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 141
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 136
La somatopausa: nuove prospettive terapeutiche 133
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 131
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 123
The role of androgens in women's health and wellbeing 119
Uso di agonisti e antagonisti dei recettori per i growth hormone secretagogues per la prevenzione e il trattamento di convulsioni ed epilessia 105
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 105
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 103
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 84
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 81
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 71
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 65
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 63
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 60
null 57
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 47
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 39
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 35
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 30
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 27
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 26
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 22
Role of nutrition in degenerative disease 8
null 6
Totale 11.413
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020140 0 0 0 0 0 0 0 0 0 0 99 41
2020/20211.599 67 73 147 171 122 150 128 143 138 164 137 159
2021/20221.033 116 109 121 83 56 75 46 46 30 86 96 169
2022/20231.866 186 484 216 182 142 268 31 118 115 19 56 49
2023/20241.156 38 58 67 77 134 281 218 52 74 23 21 113
2024/20252.102 156 234 214 190 236 166 222 133 168 380 3 0
Totale 11.413